These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

369 related items for PubMed ID: 12531339

  • 1. Experience with registered mucosal vaccines.
    Dietrich G, Griot-Wenk M, Metcalfe IC, Lang AB, Viret JF.
    Vaccine; 2003 Jan 30; 21(7-8):678-83. PubMed ID: 12531339
    [Abstract] [Full Text] [Related]

  • 2. Safety and immunogenicity of a live oral bivalent typhoid fever (Salmonella typhi Ty21a)-cholera (Vibrio cholerae CVD 103-HgR) vaccine in healthy adults.
    Cryz SJ, Que JU, Levine MM, Wiedermann G, Kollaritsch H.
    Infect Immun; 1995 Apr 30; 63(4):1336-9. PubMed ID: 7890391
    [Abstract] [Full Text] [Related]

  • 3. A review of the current status of enteric vaccines.
    Levine MM, Noriega F.
    P N G Med J; 1995 Dec 30; 38(4):325-31. PubMed ID: 9522876
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Challenges in mucosal vaccines for the control of infectious diseases.
    Azegami T, Yuki Y, Kiyono H.
    Int Immunol; 2014 Sep 30; 26(9):517-28. PubMed ID: 24914172
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Salmonella enterica serovar Typhi Ty21a expressing human papillomavirus type 16 L1 as a potential live vaccine against cervical cancer and typhoid fever.
    Fraillery D, Baud D, Pang SY, Schiller J, Bobst M, Zosso N, Ponci F, Nardelli-Haefliger D.
    Clin Vaccine Immunol; 2007 Oct 30; 14(10):1285-95. PubMed ID: 17687110
    [Abstract] [Full Text] [Related]

  • 10. [Experimental justification for combined subcutaneous immunization against cholera and typhoid fever].
    Gapochko KG, Emel'ianova OV, Ziablitsev IF.
    Zh Mikrobiol Epidemiol Immunobiol; 1984 Jan 30; (1):85-9. PubMed ID: 6702364
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Bivalent cholera and typhoid vaccine.
    Foster RH, Noble S.
    Drugs; 1999 Jul 30; 58(1):91-6; discussion 97-8. PubMed ID: 10439932
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Nonspecific effects of oral vaccination with live-attenuated Salmonella Typhi strain Ty21a.
    Pennington SH, Ferreira DM, Caamaño-Gutiérrez E, Reiné J, Hewitt C, Hyder-Wright AD, Gordon SB, Gordon MA.
    Sci Adv; 2019 Feb 30; 5(2):eaau6849. PubMed ID: 30820452
    [Abstract] [Full Text] [Related]

  • 17. Interventions to improve oral vaccine performance: a systematic review and meta-analysis.
    Church JA, Parker EP, Kirkpatrick BD, Grassly NC, Prendergast AJ.
    Lancet Infect Dis; 2019 Feb 30; 19(2):203-214. PubMed ID: 30712836
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. PaxVax CVD 103-HgR single-dose live oral cholera vaccine.
    Levine MM, Chen WH, Kaper JB, Lock M, Danzig L, Gurwith M.
    Expert Rev Vaccines; 2017 Mar 30; 16(3):197-213. PubMed ID: 28165831
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.